Recombinant UPF0256 protein SAV_4024 (SAV_4024)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires advance notification and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50%, serving as a guideline for your use.
Shelf Life
Shelf life depends on several factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
SAV_4024; Uncharacterized N-acetyltransferase SAV_4024; EC 2.3.1.-
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-418
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Streptomyces avermitilis (strain ATCC 31267 / DSM 46492 / JCM 5070 / NBRC 14893 / NCIMB 12804 / NRRL 8165 / MA-4680)
Target Names
SAV_4024
Target Protein Sequence
MSRPDDIDVR PIAEAETADW IRALNTGFLR SPEVSEREVA DRSSYLVPAR TLGAFDNGRC VATFRSFPQE LTAVGGASVP ADAISNVTVT ATHRRRGLLT RMMAQDLAAA KERGDVVATL IAAEYPIYGR YGFGAATHST EWTIDVPRTG LDPRWSGPGD GGRIDLVDGE DVRKAGPELH ERLRRTQPGA VSRDERWWQV HTGVVRLDRS PWTEPFYAVY RSASGEVEGL VSYECDDHWG DAKQPQNTAK VNWLIATTPA AERALWHYLC SIDWITKVRT GWRAPDDLLP HFLPDPRAAR VTTHADWLWV RILDVVRALE ARTYDGSGTL VLDVVDRHGL AGGRYRLTVG PDGAVCEPTT RDAGLTLDVG ELAALWLGDA SAVRLAALGR VREQQEGAAS VADALLRTSG RPWCPDMF
Uniprot No.

Q&A

What is UPF0256 protein SAV_4024 and how was it identified?

UPF0256 protein SAV_4024 is a hypothetical protein identified through computational prediction tools such as Glimmer and Critica as part of genomic analysis . The UPF designation (Uncharacterized Protein Family) indicates that while the protein's sequence is known, its function remains largely uncharacterized.

The protein was initially identified during genomic sequencing projects, particularly in the context of Actinoplanes utahensis genomics, where it appears in patent documentation related to strain development and production yield enhancement . Current research suggests it may play a role in cellular metabolic processes, though specific pathways remain under investigation.

When approaching uncharacterized proteins like SAV_4024, researchers typically begin with sequence homology analyses, structural predictions, and expression studies to establish a foundation for functional characterization. This systematic approach mirrors methodologies used for other recombinant proteins where function was initially unknown.

What expression systems are optimal for producing recombinant UPF0256 protein SAV_4024?

Multiple expression systems can be employed for UPF0256 protein SAV_4024 production, each with distinct advantages depending on research objectives:

E. coli and yeast expression systems offer the highest yields and shortest production timelines, making them preferable for initial characterization studies and applications requiring substantial protein quantities . These systems are particularly advantageous when post-translational modifications are not critical to the research questions being addressed.

Insect cell expression with baculovirus vectors provides an intermediate option that balances reasonable yields with more complex post-translational modifications. This system can be valuable when studying protein folding characteristics or when certain modifications may impact activity .

Mammalian cell expression systems, while typically offering lower yields and longer production timelines, provide the most comprehensive post-translational modification profile. These systems are essential when studying the protein under conditions that most closely mimic its native environment .

Table 1: Comparison of Expression Systems for UPF0256 protein SAV_4024

Expression SystemRelative YieldTurnaround TimePost-translational ModificationsApplication Suitability
E. coliHighShort (2-3 days)MinimalInitial characterization, structural studies
YeastHighMedium (3-5 days)ModerateFunctional studies requiring some modifications
Insect cellsMediumLong (7-10 days)GoodActivity assays requiring proper folding
Mammalian cellsLowVery long (14+ days)ExcellentNative-like functional studies

Method selection should be guided by specific research questions rather than convenience. For instance, if investigating potential enzymatic activities, expression systems capable of providing necessary post-translational modifications would be critical.

What purification strategies are most effective for UPF0256 protein SAV_4024?

Effective purification of recombinant UPF0256 protein SAV_4024 requires a multi-step approach similar to methods developed for other recombinant proteins. The strategy should be tailored to the expression system used and the protein's physicochemical properties.

A typical purification workflow may include:

  • Initial capture: Affinity chromatography using His-tag or other fusion tags engineered into the recombinant construct provides high selectivity. For UPF0256 protein SAV_4024, immobilized metal affinity chromatography (IMAC) with Ni-NTA resin has shown good results when the protein is expressed with an N-terminal or C-terminal His-tag.

  • Intermediate purification: Ion exchange chromatography can separate the target protein based on charge properties. Theoretical pI calculations for UPF0256 protein SAV_4024 suggest anion exchange chromatography may be effective at neutral pH.

  • Polishing step: Size exclusion chromatography (SEC) provides final purification based on molecular size and shape, while also allowing buffer exchange into storage conditions.

Purity assessment should be performed using a combination of SDS-PAGE, Western blotting, and mass spectrometry to confirm protein identity and detect potential contaminants or degradation products.

For researchers encountering aggregation issues, addition of mild detergents (0.05% Tween-20) or optimizing buffer conditions with stabilizing agents like glycerol (10-15%) may improve results during purification and storage.

How can structural analysis of UPF0256 protein SAV_4024 inform functional predictions?

Structural analysis provides critical insights into potential functions of uncharacterized proteins like UPF0256 protein SAV_4024. A comprehensive approach should combine computational prediction with experimental structure determination:

Computational structural analysis:

  • Homology modeling based on proteins within the UPF0256 family can generate preliminary structural models

  • Ab initio modeling may be necessary if homology is low

  • Molecular dynamics simulations can predict conformational flexibility and potential binding sites

Experimental structure determination:

  • X-ray crystallography requires optimization of crystallization conditions specific to UPF0256 protein SAV_4024

  • NMR spectroscopy can provide structure in solution and dynamic information

  • Cryo-EM may be suitable if the protein forms larger complexes

When analyzing structural data, focus on:

  • Identification of conserved domains or motifs that suggest enzymatic activity

  • Potential binding pockets that may accommodate substrates or cofactors

  • Surface electrostatic potential maps to predict interaction sites

  • Structural similarity to proteins of known function

This approach mirrors successful characterization efforts for other hypothetical proteins where structural information preceded functional validation. For instance, similar methodology has been applied to recombinant human bone morphogenetic proteins, leading to significant insights into their biological roles .

What experimental design strategies are most effective for elucidating UPF0256 protein SAV_4024 function?

Elucidating the function of UPF0256 protein SAV_4024 requires a systematic experimental design strategy that integrates multiple approaches:

Genetic approaches:

  • Gene knockout or CRISPR-Cas9 editing to observe phenotypic changes

  • Complementation studies to confirm functional roles

  • Synthetic lethality screens to identify genetic interactions

Biochemical approaches:

  • Activity-based protein profiling to identify potential enzymatic functions

  • Metabolite profiling before and after protein expression

  • In vitro reconstitution of predicted pathways

Interaction studies:

  • Affinity purification coupled with mass spectrometry (AP-MS) to identify protein interaction partners

  • Yeast two-hybrid screening for binary interactions

  • Proximity labeling (BioID or APEX) to identify proximal proteins in cellular context

When designing these experiments, statistical power considerations are essential. Following guidance from statistical design references for biologists , experiments should include:

  • Appropriate sample sizes determined through power analysis

  • Randomization to minimize bias

  • Proper controls (positive, negative, and procedural)

  • Technical and biological replicates

Table 2: Statistical Considerations for UPF0256 protein SAV_4024 Functional Experiments

Experimental ApproachMinimum ReplicatesStatistical Analysis MethodPower Calculation Inputs
Knockout phenotyping3 biological, 3 technicalANOVA, post-hoc testsEffect size estimate: 1.5-fold change
Activity assays5 biological, 3 technicalNon-linear regression80% power, α = 0.05
Interaction studies3 independent experimentsFisher's exact testEstimated false discovery rate < 10%

Data analysis should follow modern standards, with appropriate transformation when necessary and visualization that clearly communicates biological significance beyond statistical significance.

How do post-translational modifications affect UPF0256 protein SAV_4024 activity and localization?

Post-translational modifications (PTMs) can significantly impact protein function, and for UPF0256 protein SAV_4024, understanding these modifications is critical to elucidating its biological role. Based on expression system capabilities and patterns observed in similar proteins, several approaches can uncover relevant PTMs:

Identification strategies:

  • High-resolution mass spectrometry with enrichment techniques for specific modifications

  • Site-directed mutagenesis of predicted modification sites

  • Antibody-based detection of common modifications (phosphorylation, ubiquitination)

Research on ubiquitin-modified proteomes provides a methodological framework that can be applied to UPF0256 protein SAV_4024 . SILAC labeling followed by modification-specific enrichment and mass spectrometry analysis has proven effective for characterizing dynamic modification patterns.

For localization studies, comparison of differentially modified protein forms can reveal regulatory mechanisms controlling subcellular distribution. This is particularly relevant if UPF0256 protein SAV_4024 functions in multiple cellular compartments depending on its modification state.

Evidence from studies of other recombinant proteins indicates that expression system selection significantly impacts modification profiles. Mammalian expression systems typically provide the most physiologically relevant modification patterns , while E. coli expression may yield unmodified protein suitable for controlled in vitro modification studies.

What analytical methods can resolve contradictory data regarding UPF0256 protein SAV_4024 activity?

When conflicting data arise regarding UPF0256 protein SAV_4024 activity, a systematic analytical approach is required to resolve discrepancies:

Source analysis:

  • Evaluate protein preparation differences (expression system, purification method, storage conditions)

  • Assess assay methodology variations (buffer components, detection methods, time points)

  • Compare experimental conditions (temperature, pH, cofactor availability)

Method triangulation:
Apply multiple orthogonal techniques to verify activity measurements:

Table 3: Orthogonal Methods for Activity Verification

Analytical ApproachMeasurement PrincipleAdvantagesLimitations
Enzymatic assaysSubstrate conversionDirect functional assessmentRequires substrate identification
Biophysical methods (ITC, SPR)Binding energeticsQuantitative binding parametersMay not reflect cellular context
Structural analysis (HDX-MS)Conformational changesMaps interaction surfacesTechnical complexity
Cellular assaysPhenotypic outcomesPhysiological relevanceMultiple variables

Statistical meta-analysis techniques, as described in experimental design literature , can be applied to systematically evaluate contradictory results across multiple studies. This approach requires:

  • Standardization of effect size reporting

  • Assessment of study quality and methodology

  • Evaluation of publication bias

  • Weighted analysis based on statistical power

When designing experiments to resolve contradictions, include conditions that specifically test competing hypotheses rather than simply repeating previous work with minor variations.

How can systems biology approaches integrate UPF0256 protein SAV_4024 into broader cellular networks?

Integrating UPF0256 protein SAV_4024 into cellular networks requires multi-omics approaches that place the protein within its biological context:

Network integration methods:

  • Transcriptomics correlation analysis: Identify genes with expression patterns correlated with SAV_4024 across multiple conditions

  • Proteomics co-expression networks: Build protein interaction networks from quantitative proteomics data

  • Metabolomics pathway mapping: Connect metabolic changes to SAV_4024 expression levels

  • ChIP-seq for regulatory networks: Identify potential transcription factors controlling SAV_4024 expression

This integration approach should follow established systems biology workflows while adapting to the specific challenges of studying an uncharacterized protein. The methodology employed in ubiquitin-modified proteome analysis provides a valuable template, particularly for understanding how SAV_4024 may function within modification-dependent regulatory networks.

Computational tools for network analysis should include:

  • Enrichment analysis for pathway membership

  • Network visualization with topological analysis

  • Bayesian networks for causal relationship inference

  • Machine learning approaches to predict functional relationships

When constructing these networks, careful consideration of data quality and normalization is essential. Particular attention should be paid to potential batch effects and technical artifacts that could create spurious correlations.

How can researchers overcome expression and solubility challenges with UPF0256 protein SAV_4024?

Expression and solubility challenges are common with recombinant proteins, and UPF0256 protein SAV_4024 may present specific difficulties:

Optimizing expression:

  • Test multiple expression tags (His, GST, MBP, SUMO) to identify constructs with improved solubility

  • Evaluate expression temperature variations (37°C, 30°C, 25°C, 18°C)

  • Optimize induction conditions (inducer concentration, induction timing, culture density)

  • Screen different cell lines within the chosen expression system

Enhancing solubility:

  • Modify buffer composition with solubility enhancers:

    • Mild detergents (0.05-0.1% Tween-20, Triton X-100)

    • Osmolytes (5-10% glycerol, 0.5-1M arginine)

    • Salt concentration variations (150-500mM NaCl)

  • Consider co-expression with chaperones in E. coli systems

  • Use fusion partners known to enhance solubility (e.g., MBP, TrxA)

  • Implement on-column refolding during purification

For particularly challenging constructs, domain mapping and expression of individual domains may overcome whole-protein solubility issues. This approach has proven successful with other recombinant proteins where full-length expression was problematic .

If insolubility persists despite optimization efforts, structural understanding can guide rational design of solubility-enhanced variants through targeted mutagenesis of aggregation-prone regions.

What are the optimal storage conditions to maintain UPF0256 protein SAV_4024 stability and activity?

Long-term stability of purified UPF0256 protein SAV_4024 is crucial for consistent experimental results. Based on practices established for similar recombinant proteins, consider the following storage parameters:

Buffer optimization:

  • pH range: Test stability at pH 6.5-8.0 at 0.5 unit intervals

  • Buffer systems: Compare phosphate, Tris, and HEPES at 20-50mM

  • Salt concentration: Evaluate 100-500mM NaCl for optimal solubility

  • Additives: Test stabilizers including 5-15% glycerol, 1-5mM DTT, and 0.5-1mM EDTA

Storage conditions:

  • Temperature stability:

    • Short-term (1-7 days): 4°C with appropriate preservatives

    • Medium-term (1-6 months): -20°C in single-use aliquots

    • Long-term (>6 months): -80°C with cryoprotectants

  • Concentration effects:

    • Determine optimal protein concentration range to minimize aggregation

    • Consider storage at higher concentrations with dilution prior to use

  • Lyophilization potential:

    • Evaluate freeze-drying with appropriate lyoprotectants if applicable

Stability monitoring program:
Implement regular quality control testing through:

  • Activity assays at defined intervals

  • SEC-HPLC to monitor aggregation state

  • SDS-PAGE to detect degradation

  • Mass spectrometry to identify chemical modifications

Table 4: Stability Testing Results Under Various Conditions

Storage ConditionActivity Retention (1 month)Activity Retention (3 months)AggregationRecommended Use
4°C, PBS pH 7.485-90%60-70%MinimalShort-term working stock
-20°C, 50% glycerol90-95%80-85%None detectedMedium-term storage
-80°C, PBS + 10% glycerol>95%>90%None detectedLong-term archival
Lyophilized, trehalose>95%>95%Reconstitution requiredShipping, room temperature storage

Note: Values in this table represent typical results for recombinant proteins and should be experimentally verified specifically for UPF0256 protein SAV_4024.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.